SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 134 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $249,000 | +87.2% | 15,957 | +38.1% | 0.00% | – |
| Q4 2018 | $133,000 | -84.6% | 11,551 | -77.3% | 0.00% | -100.0% |
| Q3 2018 | $861,000 | +8.7% | 50,782 | -8.9% | 0.00% | 0.0% |
| Q2 2018 | $792,000 | -36.6% | 55,740 | -15.2% | 0.00% | 0.0% |
| Q1 2018 | $1,249,000 | +35.0% | 65,736 | +16.6% | 0.00% | 0.0% |
| Q4 2017 | $925,000 | +16.5% | 56,372 | +6.6% | 0.00% | 0.0% |
| Q3 2017 | $794,000 | +32.1% | 52,901 | -5.1% | 0.00% | -50.0% |
| Q3 2014 | $601,000 | -29.4% | 55,742 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $851,000 | -15.6% | 55,742 | 0.0% | 0.00% | -33.3% |
| Q1 2014 | $1,008,000 | +31.8% | 55,742 | +1.3% | 0.00% | +50.0% |
| Q4 2013 | $765,000 | +10.1% | 55,042 | -17.0% | 0.00% | 0.0% |
| Q3 2013 | $695,000 | +34.2% | 66,300 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $518,000 | +402.9% | 66,300 | +287.7% | 0.00% | – |
| Q4 2012 | $103,000 | – | 17,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |